查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945370

2026年全球感染疾病诊断检测市场报告

Infectious Disease Diagnostics Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，感染疾病诊断检测市场发展迅速，预计将以10.0%的复合年增长率成长，从2025年的422.4亿美元成长到2026年的464.8亿美元。过去几年的增长归因于多种因素，例如感染疾病病率的上升、呼吸道感染疾病发病率的增加、诊断检测设施的扩建、人们对早期诊断意识提升以及各国政府对疾病预防的日益重视。

预计未来几年，感染疾病诊断检测市场将维持强劲成长，到2030年市场规模将达到654.9亿美元，复合年增长率（CAGR）为9.0%。预测期内的成长要素包括：全球疫情风险不断上升、对快速诊断解决方案的需求日益增长、医疗诊断投资不断增加、疾病监测项目不断扩大以及热带疾病和病毒性疾病负担日益加重。预测期内的主要趋势包括：对感染疾病快速早期检测的需求不断增长、照护现场）传染病检查的普及率不断提高、分子诊断在病原体鑑定中的应用日益广泛、针对新发和再发感染疾病的诊断检测不断扩大，以及对大规模疾病筛检和监测的日益重视。

由于呼吸道感染疾病的增加，感染疾病诊断检测市场预计将会成长。呼吸道感染疾病会影响呼吸系统的各个部位，其原因是病毒和细菌透过密切接触、不卫生的环境、拥挤的居住环境以及季节性变化等因素传播。感染疾病诊断检测对于准确识别和治疗呼吸道感染疾病至关重要，能够精确检测患者检体中的病毒和细菌等病原体。例如，根据加拿大健康资讯研究所的报告，2023年因急性上呼吸道感染疾病住院的人数增加了32%，从2022年的2114人增加到2797人。

感染疾病诊断检测市场的主要企业正在开发创新技术，以快速、准确地检测关键感染疾病。感染疾病诊断能够识别病原体，例如细菌、病毒和寄生虫，从而指南诊断和治疗。例如，2025年1月，总部位于德国的生物技术公司凯杰（QIAGEN）在印度推出了其新型QIAstat-Dx症候群检测组合。该组合包括胃肠道疾病组合2和脑膜炎/脑炎组合，以及先前已获批准的呼吸道SARS-CoV-2组合，这两个组合均已获得印度中央药品标准控制组织（CDSCO）的核准。 QIAstat-Dx系统采用多重即时PCR技术及一次性试剂盒，可同时检测多种病原体。胃肠道感染疾病的检测结果大约需要1小时，中枢神经系统感染疾病的检测结果约80分钟。与传统方法相比，这些检测组合提高了诊断速度和准确性，从而能够及时治疗，改善患者预后，并减轻医疗系统的负担。该系统还具有可设定配置和云端连接功能，可实现远端监控和高效的资料管理。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球感染疾病诊断检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 感染疾病快速及早期检测的需求日益增长
    • 扩大照护现场传染病检查的应用
    • 扩大分子诊断技术在病原体鑑定上的应用
    • 扩大新发和再发感染疾病的诊断检测
    • 更重视大规模疾病筛检和监测

第五章 终端用户产业市场分析

  • 诊断检查室
  • 医院和诊所
  • 学术研究机构
  • 公共卫生研究所
  • 标准与检验组织

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球感染疾病诊断检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球感染疾病诊断检测市场规模、对比及成长率分析
  • 全球感染疾病诊断检测市场表现：规模与成长，2020-2025年
  • 全球感染疾病诊断检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 分子诊断检测、就地检验（POC​​T）感染疾病检测
  • 透过使用
  • 呼吸道疾病、人类免疫力缺乏病毒（HIV）感染、医疗相关感染疾病（HAI）、性行为感染、热带疾病
  • 最终用户
  • 诊断检查室、医院和诊所
  • 按类型细分：分子诊断测试
  • 聚合酵素链锁反应（PCR）检测、核酸增幅检查（NAAT）
  • 按类型细分：就地检验（POC​​T）感染疾病诊断测试
  • 横向流动化验、快速抗原检测、免疫检测、可携式PCR

第十章 区域与国家分析

  • 全球感染疾病诊断检测市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球感染疾病诊断检测市场：依国家/地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 感染疾病诊断检测市场：竞争格局及市场占有率（2024年）
  • 感染疾病诊断检测市场：公司估值矩阵
  • 感染疾病诊断检测市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols SA, Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, DiaSorin SpA（Luminex）, Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年感染疾病诊断检测市场：提供新机会的国家
  • 2030年感染疾病诊断检测市场：充满新机会的细分市场
  • 2030年感染疾病诊断检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIDDT01_G26Q1

Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.

The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.

Tariffs have created supply chain challenges and cost pressures in the infectious disease diagnostics testing market by increasing duties on reagents, diagnostic kits, laboratory instruments, and electronic components. These impacts have raised production and procurement costs, particularly affecting molecular diagnostics and point of care test segments, with north america and asia-pacific regions experiencing greater exposure due to reliance on imported consumables. Diagnostic laboratories and hospitals have faced pricing pressures and procurement delays. On the positive side, tariffs have encouraged local manufacturing, regional sourcing of test kits, and strengthened domestic diagnostic supply capabilities, supporting long-term market resilience.

The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with a infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $42.24 billion in 2025 to $46.48 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, rising incidence of respiratory infections, expansion of diagnostic laboratory infrastructure, growing awareness of early disease diagnosis, increased government focus on disease control.

The infectious disease diagnostics testing market size is expected to see strong growth in the next few years. It will grow to $65.49 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising risk of global pandemics, increasing demand for rapid diagnostic solutions, growing investments in healthcare diagnostics, expanding disease surveillance programs, rising burden of tropical and viral diseases. Major trends in the forecast period include rising demand for rapid and early infectious disease detection, growing adoption of point of care infectious disease tests, increasing use of molecular diagnostics for pathogen identification, expansion of diagnostic testing for emerging and re-emerging infections, growing focus on large-scale disease screening and surveillance.

The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.

Major companies in the infectious disease diagnostic testing market are developing innovative technologies to rapidly and accurately detect critical infections. Infectious disease diagnostics involves identifying pathogens, such as bacteria, viruses, or parasites, to guide diagnosis and treatment. For example, in January 2025, QIAGEN, a Germany-based biotechnology company, launched new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, alongside the previously authorized Respiratory SARS-CoV-2 Panel, all approved by India's Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system uses multiplex real-time PCR with single-use cartridges to detect multiple pathogens simultaneously, providing results in about an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels improve diagnostic speed and accuracy compared to traditional methods, enabling timely treatment, enhancing patient outcomes, and reducing healthcare system burdens. The system also offers configurable setups and cloud connectivity for remote monitoring and efficient data management.

In July 2024, Roche, a Switzerland-based company, acquired the point-of-care technology business of LumiraDx for an undisclosed amount. Through this acquisition, Roche aimed to accelerate its growth in decentralized and primary-care testing by integrating LumiraDx's multi-assay platform, which can perform immunoassay, clinical chemistry, and, with future development, molecular diagnostics. LumiraDx is a UK-based provider of infectious disease diagnostic testing.

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Diagnostics Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases
  • 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics
  • Subsegments:
  • 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs)
  • 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson And Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMerieux SA; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin SpA (Luminex); Seegene Inc.; Ortho Clinical Diagnostics Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; Trinity Biotech PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Infectious Disease Diagnostics Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Infectious Disease Diagnostics Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Infectious Disease Diagnostics Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Infectious Disease Diagnostics Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Rapid And Early Infectious Disease Detection
    • 4.2.2 Growing Adoption Of Point Of Care Infectious Disease Tests
    • 4.2.3 Increasing Use Of Molecular Diagnostics For Pathogen Identification
    • 4.2.4 Expansion Of Diagnostic Testing For Emerging And Re-Emerging Infections
    • 4.2.5 Growing Focus On Large-Scale Disease Screening And Surveillance

5. Infectious Disease Diagnostics Testing Market Analysis Of End Use Industries

  • 5.1 Diagnostic Laboratories
  • 5.2 Hospitals And Clinics
  • 5.3 Academic Research Institutes
  • 5.4 Public Health Laboratories
  • 5.5 Reference Laboratories

6. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Infectious Disease Diagnostics Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Infectious Disease Diagnostics Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Infectious Disease Diagnostics Testing Market Segmentation

  • 9.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 9.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
  • 9.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Laboratories, Hospitals And Clinics
  • 9.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
  • 9.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

10. Infectious Disease Diagnostics Testing Market Regional And Country Analysis

  • 10.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Infectious Disease Diagnostics Testing Market

  • 11.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Infectious Disease Diagnostics Testing Market

  • 12.1. China Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Infectious Disease Diagnostics Testing Market

  • 13.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Infectious Disease Diagnostics Testing Market

  • 14.1. Japan Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Infectious Disease Diagnostics Testing Market

  • 15.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Infectious Disease Diagnostics Testing Market

  • 16.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Infectious Disease Diagnostics Testing Market

  • 17.1. South Korea Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Infectious Disease Diagnostics Testing Market

  • 18.1. Taiwan Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Infectious Disease Diagnostics Testing Market

  • 19.1. South East Asia Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Infectious Disease Diagnostics Testing Market

  • 20.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Infectious Disease Diagnostics Testing Market

  • 21.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Infectious Disease Diagnostics Testing Market

  • 22.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Infectious Disease Diagnostics Testing Market

  • 23.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Infectious Disease Diagnostics Testing Market

  • 24.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Infectious Disease Diagnostics Testing Market

  • 25.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Infectious Disease Diagnostics Testing Market

  • 26.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Infectious Disease Diagnostics Testing Market

  • 27.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Infectious Disease Diagnostics Testing Market

  • 28.1. North America Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Infectious Disease Diagnostics Testing Market

  • 29.1. USA Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Infectious Disease Diagnostics Testing Market

  • 30.1. Canada Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Infectious Disease Diagnostics Testing Market

  • 31.1. South America Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Infectious Disease Diagnostics Testing Market

  • 32.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Infectious Disease Diagnostics Testing Market

  • 33.1. Middle East Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Infectious Disease Diagnostics Testing Market

  • 34.1. Africa Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Infectious Disease Diagnostics Testing Market Regulatory and Investment Landscape

36. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles

  • 36.1. Infectious Disease Diagnostics Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Infectious Disease Diagnostics Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Infectious Disease Diagnostics Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies

  • Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc.

38. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market

40. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Infectious Disease Diagnostics Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Infectious Disease Diagnostics Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Infectious Disease Diagnostics Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer